How, given the publicly available information, and economic and operating conditions, do you envisage that the market cap will increase from $75.83 million (there are 182.745 million shares outstanding) to $200 million (an increase of 2.6 times) let alone to $400 to $500 million (increases of 5.27 and 6.6 times respectively)?
It is plainly evident that the company is and or will be starved of capital to implement its growth (survival?) strategies.
To enable the company to implement its strategies it must obtain further capital (further debt funding is not a viable alternative). Therefore it would have to issue shares.
Given the current situation, any such issue would have to be at a significant discount to the most recent price of $0.415 per share.
Being generous, the company may need to raise $100 million gross, which is $95 million net (issuing costs of 5%) (to cover onerous lease and make good costs $17.5 million, further acquisition costs, strategic review, upgrade plant and equipment, and so on - lets assume that this costs $40 million in total). This will leave approximately $55 million with which to 'get on with its strategy'.
Note that there is a debt reduction requirement of $12.5 million in March 2019 and further repayment obligations of $100 million and $50 million in January and December 2020 respectively.
So, the $55 million becomes $42.5 million that is available. Probably less due to working capital changes.
The price of shares to be issued to raise the gross $100 million will be at a significant discount to the current share price ($0.415). Being realistic, the 'issuing price' of the new shares will be in the range of $0.30 (optimistic) to $0.20 (pessimistic). Therefore, the number of new shares to be issued will range from 333.33 million to 500 million. This would leave the number of shares on issue after the raising ranging from 516 million to 682 million.
If the company were to achieve a market cap of $100 million the share price would range between $0.19 and $0.15. Significant change form today's price, and alarming!
- Forums
- ASX - By Stock
- RFG
- NPAT? Its cash flow that matters
NPAT? Its cash flow that matters, page-10
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RFG (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.5¢ |
Change
0.004(5.63%) |
Mkt cap ! $186.9M |
Open | High | Low | Value | Volume |
6.8¢ | 7.6¢ | 6.8¢ | $647.9K | 8.894M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 309945 | 7.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.5¢ | 116290 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 309945 | 0.074 |
1 | 27233 | 0.073 |
2 | 147000 | 0.072 |
1 | 50000 | 0.071 |
3 | 1050000 | 0.070 |
Price($) | Vol. | No. |
---|---|---|
0.075 | 116290 | 1 |
0.076 | 245385 | 3 |
0.077 | 324761 | 10 |
0.078 | 313076 | 4 |
0.079 | 1007765 | 7 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
RFG (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online